{"title":"2022年亚的斯亚贝巴公立医院医护人员疫苗接种后SARS-CoV-2再感染及其相关因素:一项横断面研究","authors":"Enyew Belay Getahun, Nigisti Mekonnen Kebede, Fidelawit Enyew Belay, Tewodros Setegn Adissu, Zegeye Wubeshet Haile","doi":"10.1177/23333928231194804","DOIUrl":null,"url":null,"abstract":"<p><strong>Background of the study: </strong>The protection against Coronavirus variants 2019 by pre-existing antibodies due to the current vaccination or natural infection is a global concern. In Ethiopia, case reports show that a significant number of health professionals are reported to get re-infected after vaccination. There are also more studies that revealed the symptomatic SARS-COV-2 re-infection, in particular, among healthcare providers actively engaged in Addis Ababa public health facilities.</p><p><strong>Objective: </strong>This study has aimed at assessing the magnitude of post-vaccine reinfection of SARS-COV-2 and associated factors among health care providers in Addis Ababa public hospitals, Addis Ababa, 2022 G.C.</p><p><strong>Methods: </strong>A facility-based cross-sectional study was conducted from July 11 to July 30, 2022. A total of 422 health professionals were included. A simple random sampling method was employed to select 40% of the total hospitals. Then the total sample size was equally allocated to each selected hospital, and then each individual was selected purposefully. The data was collected using a structured, self-administered questionnaire. The analysis was done using SPSS version 26.0, and for data entry, EPi Info version 7.1 was used. Both bivariable and multivariable logistic regression analyses were used to determine the p-value.</p><p><strong>Results: </strong>Overall, 418 healthcare providers were enrolled in this study, making the response rate 99.05%. The magnitude of SARS-COV-2 reinfection was 60 (14.4%) (95% CI 10.8-17.9). Healthcare professionals who took infection prevention (IP) training on COVID-19 (AOR = 7.177: CI = 4.761-9.698) were associated with SARS-COV-2 reinfection; those with a history of chronic respiratory diseases (AOR = 3.029: CI = 2.406-9.133) were associated with SARS-COV-2 reinfection; health professionals who took the third dose of SARS-COV-2 vaccine (AOR = 1.75: CI = 1.14-2.68) and being a midwife were statistically significant.</p><p><strong>Conclusion and recommendation: </strong>This study showed the prevalence of SARS-COV-2 reinfection among vaccinated healthcare providers with a pre-vaccination infection history was high; IP training on COVID-19 was needed; educational status, profession, type of vaccine taken in the first dose, chronic respiratory diseases, and number of vaccinations were significantly associated with SARS-COV-2 reinfection after vaccination. Giving IP training, encouraging taking the vaccine as protocol, and using proper personal protective equipment are recommended.</p>","PeriodicalId":12951,"journal":{"name":"Health Services Research and Managerial Epidemiology","volume":"10 ","pages":"23333928231194804"},"PeriodicalIF":1.5000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/89/99/10.1177_23333928231194804.PMC10460466.pdf","citationCount":"1","resultStr":"{\"title\":\"Post-Vaccine SARS-CoV-2 Reinfection and Associated Factors Among Health Care Providers in Addis Ababa Public Hospitals, Addis Ababa, 2022: A Cross-Sectional Study.\",\"authors\":\"Enyew Belay Getahun, Nigisti Mekonnen Kebede, Fidelawit Enyew Belay, Tewodros Setegn Adissu, Zegeye Wubeshet Haile\",\"doi\":\"10.1177/23333928231194804\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background of the study: </strong>The protection against Coronavirus variants 2019 by pre-existing antibodies due to the current vaccination or natural infection is a global concern. In Ethiopia, case reports show that a significant number of health professionals are reported to get re-infected after vaccination. There are also more studies that revealed the symptomatic SARS-COV-2 re-infection, in particular, among healthcare providers actively engaged in Addis Ababa public health facilities.</p><p><strong>Objective: </strong>This study has aimed at assessing the magnitude of post-vaccine reinfection of SARS-COV-2 and associated factors among health care providers in Addis Ababa public hospitals, Addis Ababa, 2022 G.C.</p><p><strong>Methods: </strong>A facility-based cross-sectional study was conducted from July 11 to July 30, 2022. A total of 422 health professionals were included. A simple random sampling method was employed to select 40% of the total hospitals. Then the total sample size was equally allocated to each selected hospital, and then each individual was selected purposefully. The data was collected using a structured, self-administered questionnaire. The analysis was done using SPSS version 26.0, and for data entry, EPi Info version 7.1 was used. Both bivariable and multivariable logistic regression analyses were used to determine the p-value.</p><p><strong>Results: </strong>Overall, 418 healthcare providers were enrolled in this study, making the response rate 99.05%. The magnitude of SARS-COV-2 reinfection was 60 (14.4%) (95% CI 10.8-17.9). Healthcare professionals who took infection prevention (IP) training on COVID-19 (AOR = 7.177: CI = 4.761-9.698) were associated with SARS-COV-2 reinfection; those with a history of chronic respiratory diseases (AOR = 3.029: CI = 2.406-9.133) were associated with SARS-COV-2 reinfection; health professionals who took the third dose of SARS-COV-2 vaccine (AOR = 1.75: CI = 1.14-2.68) and being a midwife were statistically significant.</p><p><strong>Conclusion and recommendation: </strong>This study showed the prevalence of SARS-COV-2 reinfection among vaccinated healthcare providers with a pre-vaccination infection history was high; IP training on COVID-19 was needed; educational status, profession, type of vaccine taken in the first dose, chronic respiratory diseases, and number of vaccinations were significantly associated with SARS-COV-2 reinfection after vaccination. Giving IP training, encouraging taking the vaccine as protocol, and using proper personal protective equipment are recommended.</p>\",\"PeriodicalId\":12951,\"journal\":{\"name\":\"Health Services Research and Managerial Epidemiology\",\"volume\":\"10 \",\"pages\":\"23333928231194804\"},\"PeriodicalIF\":1.5000,\"publicationDate\":\"2023-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/89/99/10.1177_23333928231194804.PMC10460466.pdf\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Health Services Research and Managerial Epidemiology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1177/23333928231194804\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"HEALTH POLICY & SERVICES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Health Services Research and Managerial Epidemiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/23333928231194804","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"HEALTH POLICY & SERVICES","Score":null,"Total":0}
引用次数: 1
摘要
研究背景:由于当前疫苗接种或自然感染而存在的抗体对2019年冠状病毒变体的保护是一个全球关注的问题。在埃塞俄比亚,病例报告显示,据报告有相当数量的卫生专业人员在接种疫苗后再次受到感染。还有更多的研究揭示了有症状的SARS-COV-2再感染,特别是在亚的斯亚贝巴公共卫生机构积极工作的卫生保健提供者中。目的:本研究旨在评估2022年亚的斯亚贝巴州亚的斯亚贝巴公立医院卫生保健提供者接种疫苗后SARS-COV-2再感染的程度及其相关因素。方法:2022年7月11日至7月30日进行了一项基于设施的横断面研究。总共包括422名保健专业人员。采用简单随机抽样的方法,抽取医院总数的40%。然后将总样本量平均分配到每个选定的医院,然后有目的地选择每个个体。数据是通过一份结构化的、自我管理的问卷收集的。使用SPSS 26.0版本进行分析,使用EPi Info 7.1版本进行数据输入。采用双变量和多变量logistic回归分析确定p值。结果:共纳入418名医疗服务提供者,有效率为99.05%。SARS-COV-2再感染程度为60 (14.4%)(95% CI 10.8-17.9)。接受过COVID-19感染预防(IP)培训的医护人员与SARS-COV-2再感染相关(AOR = 7.177: CI = 4.761-9.698);有慢性呼吸道疾病史者(AOR = 3.029, CI = 2.406 ~ 9.133)与SARS-COV-2再感染相关;接种第三剂SARS-COV-2疫苗(AOR = 1.75: CI = 1.14-2.68)和助产士的卫生专业人员有统计学意义。结论和建议:本研究显示,接种疫苗且有接种前感染史的医护人员中,SARS-COV-2再感染的发生率较高;需要开展COVID-19知识产权培训;学历、职业、首剂疫苗种类、慢性呼吸道疾病、接种次数与接种后SARS-COV-2再感染显著相关。建议开展知识产权培训,鼓励将疫苗作为方案,并使用适当的个人防护装备。
Post-Vaccine SARS-CoV-2 Reinfection and Associated Factors Among Health Care Providers in Addis Ababa Public Hospitals, Addis Ababa, 2022: A Cross-Sectional Study.
Background of the study: The protection against Coronavirus variants 2019 by pre-existing antibodies due to the current vaccination or natural infection is a global concern. In Ethiopia, case reports show that a significant number of health professionals are reported to get re-infected after vaccination. There are also more studies that revealed the symptomatic SARS-COV-2 re-infection, in particular, among healthcare providers actively engaged in Addis Ababa public health facilities.
Objective: This study has aimed at assessing the magnitude of post-vaccine reinfection of SARS-COV-2 and associated factors among health care providers in Addis Ababa public hospitals, Addis Ababa, 2022 G.C.
Methods: A facility-based cross-sectional study was conducted from July 11 to July 30, 2022. A total of 422 health professionals were included. A simple random sampling method was employed to select 40% of the total hospitals. Then the total sample size was equally allocated to each selected hospital, and then each individual was selected purposefully. The data was collected using a structured, self-administered questionnaire. The analysis was done using SPSS version 26.0, and for data entry, EPi Info version 7.1 was used. Both bivariable and multivariable logistic regression analyses were used to determine the p-value.
Results: Overall, 418 healthcare providers were enrolled in this study, making the response rate 99.05%. The magnitude of SARS-COV-2 reinfection was 60 (14.4%) (95% CI 10.8-17.9). Healthcare professionals who took infection prevention (IP) training on COVID-19 (AOR = 7.177: CI = 4.761-9.698) were associated with SARS-COV-2 reinfection; those with a history of chronic respiratory diseases (AOR = 3.029: CI = 2.406-9.133) were associated with SARS-COV-2 reinfection; health professionals who took the third dose of SARS-COV-2 vaccine (AOR = 1.75: CI = 1.14-2.68) and being a midwife were statistically significant.
Conclusion and recommendation: This study showed the prevalence of SARS-COV-2 reinfection among vaccinated healthcare providers with a pre-vaccination infection history was high; IP training on COVID-19 was needed; educational status, profession, type of vaccine taken in the first dose, chronic respiratory diseases, and number of vaccinations were significantly associated with SARS-COV-2 reinfection after vaccination. Giving IP training, encouraging taking the vaccine as protocol, and using proper personal protective equipment are recommended.